核糖体S6蛋白激酶4变异体基因表达对乳腺癌细胞增殖的影响

doi:10.6040/j.issn.1671-7554.0.2015.1255

摘要/Abstract

摘要： 目的探讨核糖体S6蛋白激酶4变异体(RSK4m)对乳腺癌细胞株MDA-MB-231增殖的影响。方法将RSK4m的过表达载体稳定转染至乳腺癌MDA-MB-231细胞株中,分别设一个阴性对照组(mock组)及过表达RSK4m1组(OE1组)、过表达RSK4m2组(OE2组)、过表达RSK4m3组(OE3组),采用实时荧光定量PCR(qRT- PCR)和Western blotting检测RSK4m的mRNA和蛋白的表达, CCK-8试剂盒检测转染后MDA-MB-231细胞的生长增殖, 免疫共沉淀试验(CO-IP)验证热休克蛋白与RSK4变异体的相互作用。结果成功转染RSK4m慢病毒表达载体至乳腺癌MDA-MB-231细胞,其mRNA和蛋白水平均过表达(P均<0.05)。OE1组、OE2组、OE3组在24、48、72、96 h的细胞抑制率(%)与mock组相比,48、72、96 h的差异具有统计学意义(P<0.05),CO-IP结果证实热休克蛋白与RSK4m存在相互作用关系。结论 RSK4m可抑制乳腺癌细胞株MDA-MB-231的增殖,并可能与RSK4w的抑制增殖作用存在着不同的调控机制。

关键词: 核糖体S6激酶4, 乳腺肿瘤, 增殖, 互作蛋白, 变异体

Abstract: Objective To investigate the effect of expression of ribosomal protein S6 kinase 4 variants(RSK4m)on the proliferation of breast cancer cell line MDA-MB-231. Methods Lentiviral vector of RSK4 variants were constructed and transfected on breast cancer cell line MDA-MB-231. A negative control group(mock group)and overexpression RSK4m1 group(OE1 group), overexpression RSK4m2 group(OE2 group), overexpression RSK4m3 group(OE3 group)were set respectively. The expressions of three RSK4 variants were detected with qRT- PCR and Western blot. The proliferation of transfected cells was assayed by Cell Counting Kit-8. Finally, the interaction of RSK4m with heat shock proteins observed in preliminary experiments was verified with CO-IP. Results The mRNA and protein expressions of RSK4 variants were significantly up-regulated in transfected cells(all P<0.05). Compared with the mock group, the OE1, OE2 and OE3 groups had significant differences in the inhibition rate(%)at 48, 72, and 96 hour(P<0.05). CO-IP results confirmed the existence of interaction between heat shock protein and RSK4m. Conclusion The expression of RSK4m can inhibit the proliferation of MDA-MB-231. Its regulatory mechanism may differ from that of RSK4w.

Key words: Ribosomal protein S6 Kinase 4, Variant, Breast tumor, Interacting protein, Proliferation

中图分类号:

R739.9

田斯琦,刘日强,杨宁,韦薇,杨华伟. 核糖体S6蛋白激酶4变异体基因表达对乳腺癌细胞增殖的影响[J]. 山东大学学报（医学版）, 2016, 54(9): 32-36.

TIAN Siqi, LIU Riqiang, YANG Ning, WEI Wei, YANG Huawei. Effect of expression of ribosomal protein S6 Kinase 4 variants on the proliferation of breast cancer cell MDA-MB-231[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(9): 32-36.

参考文献

[1] Romeo Y, Zhang X, Roux PP. Regulation and function of the RSK family of protein kinases[J]. Biochem J, 2012, 441(2):553-569.
[2] Li Q, Jiang Y, Wei W, et al. Frequent epigenetic inactivation of RSK4 by promoter methylation in cancerous and non-cancerous tissues of breast cancer[J]. Med Oncol, 2014, 31(1):793. doi:10.1007/s12032-013-0793-3. Epub 2013 Dec 11.
[3] Dewdney SB, Rimel BJ, Thaker PH. et al. Aberrant methylation of the X-linked ribosomal S6 kinase RPS6KA6(RSK4)in endometrial cancers[J]. Clin Cancer Res, 2011, 17(8):2120-2129.
[4] 刘剑仑, 杨华伟, 陈祖舜, 等. 核糖体S6蛋白激酶4在乳腺癌中的异常表达及临床意义[J]. 中华肿瘤杂志, 2011, 33(6):452-456. LIU Jianlun, YANG Huawei, CHEN Zushun, et al. Abnormal expression of RSK-4 and its clinical significance in breast cancer[J]. Chinese Journal of Oncology, 2011, 33(6):452-456.
[5] 张晓丽, 刘剑仑, 杨华伟, 等. 抑癌基因RSK4的表达与乳腺癌细胞体外侵袭力的相关性研究[J]. 中国肿瘤临床, 2011, 38(6):308-311. ZHANG Xiaoli, LIU Jianlun, YANG Huawei, et al. The correlation between the expression of tumor suppressor gene RSK4 and the invasiveness of breast cancer cell lines in vitro[J]. Chinese Journal of Clinical Oncology, 2011, 38(6):308-311.
[6] Fan L, Strasser-Weippl K, Li JJ, et al. Breast cancer in China[J]. Lancet Oncol, 2014, 15:e279-289. doi:10.1016/S1470-2045(13)70567-9.
[7] Moritz A, Li Y, Guo A, et al. Akt-RSK-S6 kinase signaling networks activated by oncogenic receptor tyrosine kinase[J]. Sci Signal, 2010, 3(136):ra64. doi:10.1126/scisignal.2000998.
[8] Carriere A, Ray H, Blenis J, et al. The RSK factors of activating the Ras/MAPK signaling cascade[J]. Front Biosci, 2008, 13:4258-4275.
[9] 蔡君, 张涛. RSK4 蛋白在结直肠癌中的表达及临床意义[J]. 肿瘤学杂志, 2015, 21(3):252-254. CAI Jun, ZHANG Tao. Expression of RSK4 protein in colorectal cancer and its clinical significance[J]. Journal of Oncology, 2015, 21(3):252-254.
[10] Fan L, Li P, Yin Z, et al. Ribosomal s6 protein kinase 4:a prognostic factor for renal cell carcinoma[J]. Br J Cancer, 2013, 109(5):1137-1146. doi:10.1038/bjc.2013.463.
[11] Thakur A, Sun Y, Bollig A, et al. Anti-invasive and antimetastatic activities of ribosomal protein S6 kinase 4 in breast cancer cells[J]. Clin Cancer Res, 2008, 14(14):4427-4436.
[12] Nilsen TW, Graveley BR. Expansion of the eukaryotic proteome by alternative splicing[J]. Nature, 2010, 463(7280):457-463.
[13] David CJ, Manley JL. Alternative pre-mRNA splicing regulation in cancer:pathways and programs unhinged[J]. Genes Dev, 2010, 24(21):2343-2364.
[14] Ferreira EN, Rangel MC, Galante PF, et al. Alternative splicing enriched cDNA libraries identify breast cancer-associated transcripts[J]. BMC Genomic, 2010, 11 suppl 5(53):1-15.
[15] Carrasco RA, Stamm NB, Marcusson E, et al. Antisense inhibition of survivin expression as a cancer therapeutic[J]. Mol Cancer Ther, 2011, 10(2):221-232.
[16] Sun Y, Cao S, Yang M, et al. Basicanatomy and tumor biology of the RPS6KA6 gene that encodes the p90 ribosomal S6 kinase-4[J]. Oncogene, 2013, 32(14):1794-1810.
[17] 韦薇, 韩璐璐, 杨华伟, 等. 慢病毒介导的RSK4对乳腺癌MDA-MB-231细胞增殖的影响[J]. 广西医科大学学报, 2013, 30(3):329-332. WEI Wei, HAN Lulu, YANG Huawei, et al. Effect of lentiviral vector-mediated RSK4 gene on proliferation of breast cancer cell line MDA-MB-231[J]. Journal of Guangxi Medical University, 2013, 30(3):329-332.

相关文章 15

[1]	王晓磊张海涛张辉郭成浩. 舒血宁注射液对高碘致培养血管内皮细胞损伤的保护作用[J]. 山东大学学报(医学版), 2209, 47(6): 38-.
[2]	殷悦,莫振飞,吴培昕,刘金霞,魏元辉,任佳博,李春笋. GPX1基因在肺癌中的表达特征及其对肺腺癌细胞增殖、迁移、侵袭、凋亡的影响[J]. 山东大学学报 (医学版), 2026, 64(1): 65-73.
[3]	韩觉明,王晖,吴倩,郑慧玲,朱琳. B4GALNT4促进肺腺癌细胞增殖、迁移和侵袭能力[J]. 山东大学学报 (医学版), 2025, 63(7): 23-31.
[4]	李观强,施昱诚,朱可涵,胡波,黄献琛,孙元,李笃信,张喜成. 蜗牛粘液来源的活性肽SK-14促进成纤维细胞的增殖和迁移[J]. 山东大学学报 (医学版), 2025, 63(11): 1-7.
[5]	张洁,张芳芳,王靖楠,李泽宇,宋颖,李娜. circ_0000144在乳腺癌中的表达及其对乳腺癌细胞增殖、迁移和侵袭能力的影响[J]. 山东大学学报 (医学版), 2025, 63(1): 35-42.
[6]	曹华琳,贾彦召,曲莉,尹昕. CircFAT1调节miR-296-3p/MAPRE1轴对鼻咽癌细胞增殖、凋亡和放疗敏感性的影响[J]. 山东大学学报 (医学版), 2023, 61(9): 38-46.
[7]	金珊,高杰,谢玉姣,展垚,杜甜甜,王传新. 甲基转移酶PRMT5稳定USP15促进乳腺癌发生发展的作用[J]. 山东大学学报 (医学版), 2023, 61(7): 1-11.
[8]	何静,严如根,武志红,李长忠. 消癥抑癌方对卵巢癌SKOV3细胞增殖、迁移的影响[J]. 山东大学学报 (医学版), 2023, 61(5): 1-10.
[9]	董相君,李娟,孔雪,李培龙,赵文静,梁怡然,王丽丽,杜鲁涛,王传新. 环状RNA hsa_circ_0008591对乳腺癌细胞生物学行为的影响[J]. 山东大学学报 (医学版), 2023, 61(2): 78-87.
[10]	赵舸,邹存华,宋冬冬,赵淑萍. 丹参酮IIA对子宫内膜癌细胞增殖与凋亡的影响[J]. 山东大学学报 (医学版), 2022, 60(9): 53-58.
[11]	张振伟,李佳,陈克明. IGF2BP2/m6A/ITGA5信号轴调控肾透明细胞增殖和迁移[J]. 山东大学学报 (医学版), 2022, 60(9): 74-84.
[12]	申晓畅,孙一卿,颜磊,赵兴波. 芳基烃受体核转位因子样蛋白2在子宫内膜癌中的表达[J]. 山东大学学报 (医学版), 2022, 60(5): 74-80.
[13]	宋甜,付琳琳,王秋敏,杨晓,王莹,边月红,石玉华. 脂肪酸转运蛋白1在多囊卵巢综合征患者颗粒细胞中的表达[J]. 山东大学学报 (医学版), 2022, 60(2): 22-26.
[14]	亓梦雨,周敏然,孙洺山,李世洁,陈春燕. T大颗粒淋巴细胞白血病合并原发性骨髓纤维化1例[J]. 山东大学学报 (医学版), 2022, 60(2): 118-120.
[15]	李卉,姜朝阳,刘岩,张曼. 组蛋白去乙酰化酶SIRT1调控氧化低密度脂蛋白诱导巨噬细胞凋亡的表达[J]. 山东大学学报 (医学版), 2022, 60(1): 6-12.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed